For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza
The public at large is cautioned of fraudulent activities and false commitments using the name of Cadila.

News & Events

  • CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza Read More >>
Get a Quote
Celecoxib API Manufacturer

We are Anti inflammatory drug manufacturer and Arthritis bulk drug manufacturer named Celecoxib. The CAS number of Celecoxib is 169590-42-5.

Prescription medication is used to treat acute pain and inflammation, Celecoxib helps patients suffering with Acute Pain, Osteoarthritis, Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Painful Menstruation, Primary Dysmenorrhea, and Ankylosing Spondylitis. It is Classified as a COX-2 inhibitor. Celecoxib is very effective in relieving pain as it stops the production of the COX-2 enzyme, which is a cause of inflammation and pain.

Cadila Pharmaceuticals Limited is one of the USFDA approved pharmaceutical companies based in India. Our Active Pharmaceutical Ingredients (APIs) plant is approved by USFDA. One of the main objective of our company is to synthesize Active Pharmaceutical Ingredients (APIs) of the highest quality in cost effective manner. We are market leader in synthesizing APIs.

We are major Celecoxib manufacturer, supplier and exporter. We export Celecoxib majorly to Europe, North America, Middle East countries.

Counterfeit Drugs: In case of any information on /or availability of counterfeit products... Read More © 2019 Cadila Pharmaceuticals all right reserved
Corporate identification No : U24231GJ1991PLC015132
Cadila Pharmaceuticals